BioHemp International, Inc. Aktie Other OTC
Aktien
A2N8AM
US09076B1052
BKIT
Pharmazeutika
Manager | Titel | Alter | Seit |
---|---|---|---|
Daniel Blum
CEO | Chief Executive Officer | 35 | 15.05.19 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Daniel Blum
CEO | Chief Executive Officer | 35 | 15.05.19 |
% 1. Jan. | Kap. | |
---|---|---|
+40.73% | 739 Mrd. | |
+32.83% | 598 Mrd. | |
-6.30% | 353 Mrd. | |
+15.15% | 318 Mrd. | |
+4.05% | 285 Mrd. | |
+15.00% | 240 Mrd. | |
+9.78% | 210 Mrd. | |
-5.52% | 206 Mrd. | |
+6.17% | 164 Mrd. |